Expression and promoter methylation of mitogen-activated protein kinase 1 in tumor and marginal cells of breast cancer

CONCLUSION: Our findings suggest that while MAPK1 expression, might be a promising biomarker for evaluating oncogenic activity in patients suspected of BCa. We were not able to detect a prognostic/diagnostic role for MAPK1 promoter methylation.PMID:38143331 | DOI:10.3233/BD-230001
Source: Breast Disease - Category: Cancer & Oncology Authors: Source Type: research